scispace - formally typeset
M

Marie-Anne Raquin

Researcher at Institut Gustave Roussy

Publications -  37
Citations -  2815

Marie-Anne Raquin is an academic researcher from Institut Gustave Roussy. The author has contributed to research in topics: Cancer & Procarbazine. The author has an hindex of 22, co-authored 37 publications receiving 2666 citations.

Papers
More filters
Journal ArticleDOI

Long-term intellectual outcome in children with posterior fossa tumors according to radiation doses and volumes.

TL;DR: This preliminary study further supports the rationale for de-escalation of CSI doses and volumes in standard-risk PF tumors and shows a significant correlation between the full-scale IQ score and the CSI dose.
Journal ArticleDOI

Treatment of medulloblastoma with postoperative chemotherapy alone: an SFOP prospective trial in young children

TL;DR: Conventional chemotherapy alone can be used to cure children with non-metastatic medulloblastoma who have gross total resection confirmed by early radiological assessment, but is not sufficient for treatment of those with metastatic or incompletely resected medullOBlastoma.
Journal ArticleDOI

Postoperative Chemotherapy Without Irradiation for Ependymoma in Children Under 5 Years of Age: A Multicenter Trial of the French Society of Pediatric Oncology

TL;DR: A significant proportion of children with ependymoma can avoid radiotherapy with prolonged adjuvant chemotherapy, and deferring irradiation at the time of relapse did not compromise overall survival of the entire patient population.
Journal ArticleDOI

Risk of Secondary Leukemia After a Solid Tumor in Childhood According to the Dose of Epipodophyllotoxins and Anthracyclines: A Case-Control Study by the Société Française d’Oncologie Pédiatrique

TL;DR: Both epipodophyllotoxins and anthracyclines increase the risk of secondary leukemia, and the current challenge is to minimize the mutagenic effects of these drugs by diminishing cumulative doses without losing the therapeutic benefits.